If you look at the type of partnerships deals done by the [possible partner], the events of today make perfect sense.
The company I'm thinking of likes to come in, take control of the clinical trial by making an equity investment and dangling significant milestone payments, and much prefers to operate out of the spotlight. When the press comes calling after such a partnership is announced, you want an experienced IR/PR person to control the narrative. Better press means better investment interest which means better share price for all of us.
Also I personally don't believe PMCB sought this guy out. As a friend of a Board member, I think he has been devastated by the loss of a loved one to pancreatic cancer and this is his way to help others down the road.
You have to admit, it would make for a visceral CNBC clip to have someone who experienced personal loss being a champion for a technology that could help others one day soon.
News 
Market Data 
Discover 
